6-K ·Filed Aug 3, 2026

BLX

BLADEX, INC.
MIXED
Impact 5/10
Horizonweeks Processed2mo ago SEC0001628280-26-051633
Notable filing: 6-K
Actionable Insight ◆ Mixed

Modest beat on revenue and net income is offset by credit quality deterioration and slightly lower H1 EPS attributable to common. Monitor next quarter for trends in non-accruing loans and the impact of AT1 coupon payments on common EPS. Dividend yield remains supported at current rate.

DirectionMixed
Confidencehigh
Horizonweeks
Latest settled — T+20d
BLX ▼ -9.88% at T+20d
NEUTRAL call ✗ call lost -9.88% · α vs SPY -11.12% · entry $59.83 → $53.92
Next anchor: T+60d in 25d
Latest observation: T+39 -3.76% FF3 residual α
Entry anchored
Aug 3, 11:58 AM ET
via exchange tick
T+1d
-1.20%
call -1.20% · α -3.01%
$59.11
settled 8w ago
T+5d
-6.38%
call -6.38% · α -8.41%
$56.01
settled 8w ago
T+20d
-9.88%
call -9.88% · α -11.12%
$53.92
settled 5w ago
T+60d
—
call — · α —
—
in 25d

Price Chart

Loading chart...

Executive Summary

Bladex reported Q2 2026 total revenues of $98.9M (+9.8% YoY) and net income of $66.5M (+3.5% YoY), with EPS of $1.77 (+2.3% YoY). Strong loan growth of 14.5% YTD was partially offset by a doubling of non-accruing loans to $75.1M and a higher impairment charge of $13.3M (+30% YoY). The capital adequacy ratio declined to 14.3% but remains well above regulatory minimums.

Key Facts

  • Q2 2026 total revenues of $98.9M, up 9.8% YoY from $90.0M
  • Q2 2026 net income of $66.5M, up 3.5% YoY from $64.2M
  • Q2 2026 EPS of $1.77, up 2.3% YoY from $1.73
  • H1 2026 EPS attributable to ordinary shareholders of $3.08 vs $3.13 in H1 2025, a 1.6% decline after AT1 coupon deduction
  • Loan portfolio grew 14.5% to $10.5B from $9.1B at Dec 2025
  • Non-accruing loans increased to $75.1M from $38.7M at Dec 2025
  • Impairment losses on financial instruments of $13.3M vs $10.2M in H1 2025, up 30%
  • Capital adequacy ratio of 14.3%, down from 15.5% at Dec 2025
  • Quarterly dividend of $0.6875 per share declared for Q2 2026, payable Aug 25

Financial Impact

Q2 revenue grew $8.9M YoY; net income up $2.3M. Credit quality deterioration adds ~$3.1M in incremental impairment YoY. Capital buffer remains strong with $1.76B equity.

revenuenet incomeepsloan growthnon-accruing loanscapital adequacy

Risk Factors

  • Doubling of non-accruing loans to $75.1M signals potential credit stress in the portfolio
  • Capital adequacy declining from 15.5% to 14.3% reduces buffer above regulatory minimums
  • H1 EPS attributable to common shares declined 1.6% YoY due to AT1 coupon

Market Snapshot

Exchange
NYSE
Sector
Commercial Banks, NEC
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001628280-26-051633
Document: 0001628280-26-051633-index-headers.html0001628280-26-051633
Document: 0001628280-26-051633-index.html0001628280-26-051633
Document: 0001628280-26-051633.txt0001628280-26-051633
4 reports for BLX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BLX — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$53.92 $56.33▲ +4.47%▲ +4.61%$54.78 (+1.59%)
Aug 3, 2026
8w ago
6-K
MIXED ★ 5/10
$59.83 $56.01▼ −6.38%▼ −8.41%$54.78 (−8.44%)
Jun 6, 2026
16w ago
6-K
NEUTRAL ★ 2/10
$56.04 $58.67▲ +4.69%▲ +2.58%$54.78 (−2.25%)
Apr 20, 2026
23w ago
20-F
BULLISH ★ 7/10
$55.56 $53.29▼ −4.08%▼ −5.16%$54.78 (−1.40%)
Showing 4 of 4

US Market Status

Market Closed — Opens Mon (64h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access